Syros Pharmaceuticals (SYRS)
(Delayed Data from NSDQ)
$5.04 USD
-0.06 (-1.18%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $5.05 +0.01 (0.20%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth F Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/8/24 |
---|---|
Current Quarter | -0.89 |
EPS Last Quarter | -1.19 |
Last EPS Surprise | 3.25% |
ABR | 1.00 |
Earnings ESP
|
0.00% |
---|---|
Current Year | -3.78 |
Next Year | -3.30 |
EPS (TTM) | -4.69 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 1.30M | 1.30M | 5.00M | 67.70M |
# of Estimates | 1 | 1 | 1 | 2 |
High Estimate | 1.30M | 1.30M | 5.00M | 130.40M |
Low Estimate | 1.30M | 1.30M | 5.00M | 5.00M |
Year ago Sales | 2.95M | 2.83M | 9.94M | 5.00M |
Year over Year Growth Est. | -55.93% | -54.06% | -49.68% | 1,254.00% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.89 | -0.93 | -3.78 | -3.30 |
# of Estimates | 3 | 3 | 3 | 3 |
Most Recent Consensus | -1.20 | -1.21 | -4.77 | -4.94 |
High Estimate | -0.72 | -0.77 | -3.24 | -0.91 |
Low Estimate | -1.20 | -1.21 | -4.77 | -4.94 |
Year ago EPS | -0.85 | -1.30 | -4.70 | -3.78 |
Year over Year Growth Est. | -4.71% | 28.46% | 19.57% | 12.61% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 2 | 1 | 0 |
Up Last 60 Days | 2 | 3 | 1 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 1 | 1 |
Down Last 60 Days | 1 | 0 | 2 | 1 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.89 | -0.93 | -3.78 | -3.30 |
7 Days Ago | -0.89 | -0.93 | -3.78 | -3.30 |
30 Days Ago | -0.82 | -0.99 | -3.77 | -2.11 |
60 Days Ago | -0.88 | -1.01 | -3.75 | -2.52 |
90 Days Ago | -0.88 | -1.01 | -3.75 | -2.52 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.89 | -0.93 | -3.78 | -3.30 |
Zacks Consensus Estimate | -0.89 | -0.93 | -3.78 | -3.30 |
Earnings ESP | 0.00% | 0.00% | 0.00% | 0.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -1.19 | -1.35 | -1.30 | -0.85 | NA |
Estimate | -1.23 | -1.12 | -1.11 | -1.12 | NA |
Difference | 0.04 | -0.23 | -0.19 | 0.27 | -0.03 |
Surprise | 3.25% | -20.54% | -17.12% | 24.11% | -2.58% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more